Increased serum HMGB1 is related to oxidative stress in patients with atrial fibrillation
Author(s) -
Yongbo Wu,
Kai Zhang,
Lin Zhao,
Jie Guo,
Xiaorong Hu,
Zhiqiang Chen
Publication year - 2013
Publication title -
journal of international medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 57
eISSN - 1473-2300
pISSN - 0300-0605
DOI - 10.1177/0300060513503917
Subject(s) - malondialdehyde , medicine , oxidative stress , hmgb1 , superoxide dismutase , atrial fibrillation , endocrinology , gastroenterology , inflammation
Objective To investigate the relationship between the serum concentration of high mobility group box 1 protein (HMGB1) and oxidative stress in patients with atrial fibrillation (AF).Methods Patients with AF (paroxysmal or persistent) and matched control subjects were recruited. Serum HMGB1 concentration and malondialdehyde (MDA) and superoxide dismutase (SOD) activity were determined.Results Serum hs-CRP and HMGB1 concentrations and MDA activity were significantly higher in patients with persistent AF ( n = 33) or paroxysmal AF ( n = 53) than in controls ( n = 30). Serum SOD activity was significantly lower in both patient groups than in controls. In the patient group, HMGB1 concentration was significantly positively correlated with MDA activity ( r = 0.535), and negatively correlated with SOD activity ( r = −0.491). MDA, SOD, hs-CRP and HMGB1 were significant independent predictors of AF.Conclusions Increased oxidative stress may contribute to increased HMGB1 concentrations in patients with AF. Inhibition of oxidative stress may provide a potential therapeutic strategy for AF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom